Efficacy Evaluation of Bevacizumab Combined with Capecitabine in the Treatment of HER2-Negative Metastatic Breast Cancer: A Meta-Analysis

Figure 2

Forest diagram and subgroup analysis of bevacizumab combined with capecitabine for RDP results.